foxo4-dri senolytic peptide human trials trial Development of a novel senolytic by precise disruption of FOXO4 Peptide inhibitors targeting FOXO4-p53 interactions – Development of a novel senolytic
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14










:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)


















